DuPont de Nemours, Inc. · NYSE:DD

DuPont de Nemours — DuPont — Q3 2014 Earnings Presentation

38 slides from DuPont de Nemours's earnings presentation, Oct 28, 2014

  1. Slide 1: DuPont Third Quarter 2014 Earnings Conference Call

    DuPont Third Quarter 2014 Earnings Conference Call October 28, 2014

  2. Slide 2: Regulation G and Forward-Looking Statements

    Regulation G The attached charts include company information that does not conform to generally accepted accounting principles (GAAP). Management believes that an analysis of this data is meaningful to investors because it provides insight with respect to ongoing operating results of the company. Th

  3. Slide 3: 3Q 2014 Financial Highlights

    3Q 2014 Financial Highlights* $ in millions, except EPS vs. 3Q14 vs. 3Q13 YTD14 YTD13 EPS* Operating earnings** $0.54 20% $3.29 0% GAAP earnings $0.47 68% $3.17 11% vs. 3Q14 vs. 3Q13 YTD14 YTD13 Consolidated Net Sales* $7,511 (3%) $27,345 (2%) Volume 1% - Local Prices (1%) (1%) Currency Impact - - P

  4. Slide 4: 3Q 2014 Segment Operating Earnings Variance

    3Q 2014 Segment Operating Earnings* Variance $24 $3 $2 ($3) ($12) $7 $19 $30 $923 Segment $853 Operating Earnings* Segment Operating Earnings* 3Q13 S&P N&H Ag Perf Mtls IB E&C Perf Chem Other 3Q14 Key Takeaways • Safety & Protection delivered strong results due to continued productivity • Nutrition

  5. Slide 5: Global Sales – Regional Highlights

    Global Sales – Regional Highlights 3Q 2014 Sales by Region 3Q 2014 Sales YOY % Change Region % U.S. & Canada 32% Worldwide -3% Latin America 19% U.S. & Canada -5% Developed EMEA -3% Developing Developed EMEA Developed Asia -4% Asia 6% 10% Developing Markets -1% Developed Developing EMEA Developing A

  6. Slide 6: 3Q 2014 Operating EPS Variance

    3Q 2014 Operating EPS* Variance $0.09 ($0.03) $0.01 $0.01 $0.01 $0.45 $0.54 Operating* Operating* EPS EPS 3Q13 Segment results Portfolio changes Interest Exp Taxes Lower shares 3Q14 Key Takeaways • Segment earnings, excluding portfolio changes were up $0.09. • Portfolio changes include the sale of G

  7. Slide 7: Balance Sheet and Cash

    Balance Sheet and Cash September 30, 2014 Free Cash Flow* Free Cash Flow • ~$0.4B improvement YOY YTD 13 YTD 14 • Lower tax payments from the 2013 sale of 0.0 Performance Coatings -1.0 $ Billions -2.0 Balance Sheet -3.0 • $8.6B net debt** -4.0 • $2.0B in share repurchases/prepayments YTD – about 28

  8. Slide 8: Other Financial Highlights

    Other Financial Highlights • Redesign initiative on track and contributed $0.02 per share to operating earnings in the quarter • On track to complete Performance Chemicals separation in mid 2015; Initial Form 10 filing anticipated December 2014 • 2014 Full Year Operating EPS* outlook expected to be

  9. Slide 9: Safety & Protection

    Safety & Protection Protection Technologies (DPT), Building Innovations (BI), Sustainable Solutions (DSS) 3Q Sales* 3Q Comments • Sales of ~$1B down 1% due primarily to a portfolio 1.2 change 1.0 • Higher volumes in industrial markets for Kevlar® aramid $ in Billions 0.8 fiber and Nomex® thermal res

  10. Slide 10: Nutrition & Health

    Nutrition & Health 3Q Sales* 3Q Comments 1.0 • Sales were 4% higher from volume growth in specialty proteins, probiotics and cultures and continued momentum 0.8 in enablers $ in Billions 0.6 • Operating earnings of $100 million increased 23% from 0.4 higher sales, mix enrichment, productivity action

  11. Slide 11: Agriculture

    Agriculture Pioneer, Crop Protection 3Q Sales* 3Q Comments • Challenging Ag environment with declining commodity prices and lower corn-planted area 2.0 • 3Q sales were 4% lower • Volume growth from new product launches in 1.5 $ in Billions insecticides and fungicides was more than offset by 1.0 lowe

  12. Slide 12: Performance Materials

    Performance Materials*** Performance Polymers (DPP), Packaging & Industrial Polymers (P&IP) 3Q Sales* 3Q Comments • Sales down 3% due to the impact of GLS/Vinyls sale 2.0 • Operating earnings were up 1% on solid demand in 1.6 automotive, construction and industrial demand. $ in Billions 1.2 • Prior

  13. Slide 13: Industrial Biosciences

    Industrial Biosciences 3Q Sales* 3Q Comments 0.4 • Sales of $318 million up 4% on higher volumes 0.3 • Continued solid enzyme demand in ethanol, food and $ in Billions 0.2 animal nutrition segments 0.1 • Sorona® polymer sales flat on lower demand for residential carpet partially offset by increased

  14. Slide 14: Electronics & Communications

    Electronics & Communications 3Q Sales* 3Q Comments 1.0 • Sales were 2% lower as volume growth in several 0.8 product lines was more than offset by competitive pressures impacting Solamet® paste $ in Billions 0.6 0.4 • Operating earnings of $94 million were $3 million lower as lower sales and a decre

  15. Slide 15: Performance Chemicals

    Performance Chemicals*** Titanium Technologies (DTT), Chemical & Fluoroproducts (DC&F) 3Q Sales* 3Q Comments 2.0 • Sales of $1.6 billion were down 8% due primarily to a 1.5 portfolio change $ in Billions • Lower segment prices, principally Ti02 and fluoroproducts, 1.0 impacted operating earnings 0.5

  16. Slide 16: Appendix 1: Third Quarter 2014 Segment Commentary

    APPENDIX 1: THIRD QUARTER 2014 SEGMENT COMMENTARY This data should be read in conjunction with the Company’s third quarter earnings news release dated October 28, 2014 and DuPont’s 3Q 2014 Earnings Conference Call presentation materials and reconciliations of non-GAAP to GAAP measures included in th

  17. Slide 17: Segment Commentary: Safety & Protection

    Segment Commentary Third Quarter Earnings 2014 Safety & Protection Sales of $1 billion were down 1 percent as higher volumes in industrial markets were more than offset by the loss of sales due to a portfolio change. Improved Nomex® thermal resistant fiber and Kevlar® aramid fibers demand was partia

  18. Slide 18: Segment Commentary: Nutrition & Health

    Segment Commentary Third Quarter Earnings 2014 Nutrition & Health This was another strong quarter for our Nutrition & Health segment. Sales were up 4 percent led by volume growth in specialty proteins, probiotics and cultures and continued momentum in enablers. We continue to expand in emerging mark

  19. Slide 19: Segment Commentary: Agriculture

    Segment Commentary Third Quarter Earnings 2014 Agriculture In our Agriculture segment, third quarter results are largely driven by the summer growing season in Latin America. A seasonal operating loss of $55 million was slightly better than the prior year and in line with our expectations heading in

  20. Slide 20: Segment Commentary: Agriculture (continued)

    Segment Commentary Third Quarter Earnings 2014 Agriculture (continued) lower during the quarter, particularly in North America, as growers reduced some applications and distributor inventories remain elevated. Moving to the seed business, third quarter sales declined 16 percent as corn planted area

  21. Slide 21: Segment Commentary: Agriculture (continued)

    Segment Commentary Third Quarter Earnings 2014 Agriculture (continued) Turning to the outlook, the fourth quarter in Agriculture is driven by the completion of the Brazil summer season and shipments to position product for the upcoming Safrinha season in Brazil and for the 2015 Northern hemisphere s

  22. Slide 22: Segment Commentary: Performance Materials

    Segment Commentary Third Quarter Earnings 2014 Performance Materials Sales were down 3 percent due to the impact of the sale of GLS/Vinyls. Absent the portfolio change, volumes and prices increased across the segment. Operating earnings were up 1 percent on solid demand in automotive, construction,

  23. Slide 23: Segment Commentary: Industrial Biosciences

    Segment Commentary Third Quarter Earnings 2014 Industrial Biosciences Industrial Biosciences sales of $318 million were 4 percent higher on continued solid enzyme demand for ethanol production. Operating earnings of $47 million were up 4 percent, primarily driven by higher volumes. Ethanol industry

  24. Slide 24: Segment Commentary: Electronics & Communications

    Segment Commentary Third Quarter Earnings 2014 Electronics & Communications Sales in Electronics & Communications were 2 percent lower in the quarter. Volume growth in several product lines was more than offset by competitive pressures impacting Solamet® paste. Operating earnings of $94 million were

  25. Slide 25: Segment Commentary: Performance Chemicals

    Segment Commentary Third Quarter Earnings 2014 Performance Chemicals Segment sales of approximately $1.6 billion were down 8 percent due primarily to a portfolio change in Chemicals and Fluoroproducts. Prices for the segment were lower in aggregate with slightly higher volumes in Chemicals and Fluor

  26. Slide 26: Appendix 2: Supplemental Quarterly Information and Reconciliations of Non-GAAP Measures

    Appendix 2: Supplemental Quarterly Information and Reconciliations of Non-GAAP Measures

  27. Slide 27: Quarterly Supplemental Financial Data and Non-GAAP Reconciliations Index

    E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES QUARTERLY SUPPLEMENTAL FINANCIAL DATA AND NON-GAAP RECONCILIATIONS (UNAUDITED) SEPTEMBER 30, 2014 INDEX PAGE SELECTED OPERATING RESULTS 27 SELECTED INCOME STATEMENT DATA 28 SEGMENT SALES 29 SEGMENT PRETAX OPERATING INCOME 30 SEGMENT

  28. Slide 28: Selected Operating Results

    E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES SELECTED OPERATING RESULTS (UNAUDITED) (dollars in millions) Year Year Year Year 2014 3Q14 2Q14 1Q14 2013 4Q13 3Q13 2Q13 1Q13 2012 4Q12 3Q12 2Q12 1Q12 2011 INCOME STATEMENT DATA Consolidated Net Sales 27,345 7,511 9,706 10,128 35,734

  29. Slide 29: Selected Income Statement Data – Operating Earnings

    E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES SELECTED INCOME STATEMENT DATA OPERATING EARNINGS (UNAUDITED) (dollars in millions, except per share) Year Year Year Year 2014 3Q14 2Q14 1Q14 2013 4Q13 3Q13 2Q13 1Q13 2012 4Q12 3Q12 2Q12 1Q12 2011 Consolidated Net Sales 27,345 7,511

  30. Slide 30: Segment Sales

    E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES SEGMENT SALES (UNAUDITED) (dollars in millions) SEGMENT SALES Year Year Year Year 2014 3Q14 2Q14 1Q14 2013 4Q13 3Q13 2Q13 1Q13 2012 4Q12 3Q12 2Q12 1Q12 2011 Agriculture 9,572 1,563 3,615 4,394 11,739 1,806 1,633 3,631 4,669 10,426 1,

  31. Slide 31: Income from Continuing Operations

    E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES INCOME FROM CONTINUING OPERATIONS (UNAUDITED) (dollars in millions) SEGMENT PRETAX OPERATING INCOME (LOSS) Year Year Year Year 2014 3Q14 2Q14 1Q14 2013 4Q13 3Q13 2Q13 1Q13 2012 4Q12 3Q12 2Q12 1Q12 2011 Agriculture 2,176 (55) 789 1,44

  32. Slide 32: Operating Earnings

    E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES OPERATING EARNINGS (UNAUDITED) (dollars in millions) SEGMENT OPERATING EARNINGS Year Year Year Year 2014 3Q14 2Q14 1Q14 2013 4Q13 3Q13 2Q13 1Q13 2012 4Q12 3Q12 2Q12 1Q12 2011 Agriculture 2,223 (55) 836 1,442 2,483 88 (62) 941 1,516 2

  33. Slide 33: Significant Items by Segment – Pretax Operating Income

    E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES SIGNIFICANT ITEMS BY SEGMENT - PRETAX OPERATING INCOME (UNAUDITED) (dollars in millions) SEGMENT PRETAX IMPACT OF Year Year Year Year SIGNIFICANT ITEMS 2014 3Q14 2Q14 1Q14 2013 4Q13 3Q13 2Q13 1Q13 2012 4Q12 3Q12 2Q12 1Q12 2011 Agricu

  34. Slide 34: Reconciliation of Non-GAAP Measures

    E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES RECONCILIATION OF NON-GAAP MEASURES (UNAUDITED) (dollars in millions, except per share) Year Year Year Year 2014 3Q14 2Q14 1Q14 2013 4Q13 3Q13 2Q13 1Q13 2012 4Q12 3Q12 2Q12 1Q12 2011 RECONCILIATION OF DILUTED EPS (1) Operating EPS 3.

  35. Slide 35: Reconciliation of Non-GAAP Measures: Net Debt

    E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES RECONCILIATION OF NON-GAAP MEASURES (UNAUDITED) (dollars in millions) Sep-14 Jun-14 Mar-14 Dec-13 Sep-13 Jun-13 Mar-13 Dec-12 Sep-12 Jun-12 Mar-12 Dec-11 CALCULATION OF NET DEBT Cash and Cash Equivalents 3,982 4,174 3,782 8,941 7,005

  36. Slide 36: Reconciliation of Non-GAAP Measures: Segment PTOI Margin

    E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES RECONCILIATION OF NON-GAAP MEASURES (UNAUDITED) Year Year Year Year 2014 3Q14 2Q14 1Q14 2013 4Q13 3Q13 2Q13 1Q13 2012 4Q12 3Q12 2Q12 1Q12 2011 SEGMENT PTOI MARGIN % (PTOI / Segment Sales) (1) Agriculture 22.7% -3.5% 21.8% 32.8% 18.2%

  37. Slide 37: Reconciliation of Base Income Tax Rate to Effective Income Tax Rate

    E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES RECONCILIATION OF BASE INCOME TAX RATE TO EFFECTIVE INCOME TAX RATE (UNAUDITED) Base income tax rate is defined as the effective income tax rate less the effect of exchange gains (losses), significant items and non-operating pension/

  38. Slide 38: Copyright and trademark notice

    Copyright©©2014 Copyright 2014DuPont DuPontororitsits affiliates. affiliates. All All rights rights reserved. reserved. The DuPont DuPontOval OvalLogo, Logo,DuPont™, DuPont™, The Themiracles miracles of science™ of science™ and all and all products products, unlessdenoted otherwise with indicated, ™

DuPont — Q3 2014 Earnings Presentation on 6ix